Anti-LAMB1/ CLM/ LIS5 functional antibody
Anti-LAMB1/ CLM/ LIS5 functional antibody for cell culture, ELISA & in-vivo assay
Go to LAMB1/LAMB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0300-Ab-1/ GM-Tg-hg-SE0300-Ab-2 | Anti-Human LAMB1 monoclonal antibody | Human |
GM-Tg-rg-SE0300-Ab-1/ GM-Tg-rg-SE0300-Ab-2 | Anti-Rat LAMB1 monoclonal antibody | Rat |
GM-Tg-mg-SE0300-Ab-1/ GM-Tg-mg-SE0300-Ab-2 | Anti-Mouse LAMB1 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0300-Ab-1/ GM-Tg-cynog-SE0300-Ab-2 | Anti-Cynomolgus/ Rhesus macaque LAMB1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0300-Ab-1/ GM-Tg-felg-SE0300-Ab-2 | Anti-Feline LAMB1 monoclonal antibody | Feline |
GM-Tg-cang-SE0300-Ab-1/ GM-Tg-cang-SE0300-Ab-2 | Anti-Canine LAMB1 monoclonal antibody | Canine |
GM-Tg-bovg-SE0300-Ab-1/ GM-Tg-bovg-SE0300-Ab-2 | Anti-Bovine LAMB1 monoclonal antibody | Bovine |
GM-Tg-equg-SE0300-Ab-1/ GM-Tg-equg-SE0300-Ab-2 | Anti-Equine LAMB1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0300-Ab-1/ GM-Tg-hg-SE0300-Ab-2; GM-Tg-rg-SE0300-Ab-1/ GM-Tg-rg-SE0300-Ab-2; GM-Tg-mg-SE0300-Ab-1/ GM-Tg-mg-SE0300-Ab-2; GM-Tg-cynog-SE0300-Ab-1/ GM-Tg-cynog-SE0300-Ab-2; GM-Tg-felg-SE0300-Ab-1/ GM-Tg-felg-SE0300-Ab-2; GM-Tg-cang-SE0300-Ab-1/ GM-Tg-cang-SE0300-Ab-2; GM-Tg-bovg-SE0300-Ab-1/ GM-Tg-bovg-SE0300-Ab-2; GM-Tg-equg-SE0300-Ab-1/ GM-Tg-equg-SE0300-Ab-2 |
Products Name | Anti-LAMB1 monoclonal antibody |
Format | mab |
Target Name | LAMB1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-LAMB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0300-Ag-1 | Recombinant multi-species LAMB1/ CLM/ LIS5 protein |
Target information
Target ID | GM-SE0300 |
Target Name | LAMB1 |
Gene ID | 3912,16777,298941,702111,475882,101080367,520030,100060360 |
Gene Symbol and Synonyms | CLM,D130003D08Rik,Lamb-1,LAMB1,Lamb1-1,LIS5 |
Uniprot Accession | P07942 |
Uniprot Entry Name | LAMB1_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000091136 |
Target Classification | N/A |
The target: LAMB1, gene name: LAMB1, also named as CLM, LIS5. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 1. The beta 1 chain has 7 structurally distinct domains which it shares with other beta chain isomers. The C-terminal helical region containing domains I and II are separated by domain alpha, domains III and V contain several EGF-like repeats, and domains IV and VI have a globular conformation. Laminin, beta 1 is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin 1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. A sequence in the beta 1 chain that is involved in cell attachment, chemotaxis, and binding to the laminin receptor was identified and shown to have the capacity to inhibit metastasis. [provided by RefSeq, Aug 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.